EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Atrial Fibrillation
- Intracranial Hemorrhages
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Prospective, randomized, open, blinded end-point (PROBE), multicenter international trialMasking: Single (Outcomes Assessor)Masking Description: open label study where outcomes assessor is blinded to treatment allocationPrimary Purpose: Prevention
Participation Requirements
- Age
- Between 45 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03950076
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Ashkan Shoamanesh, MD. FRCPC Population Health Research Institute
Get Well Soon